Subclinical Myocardial Impairment in Metabolic Diseases

Elliott, 2008, Classification of the cardiomyopathies: a position statement from the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases, Eur Heart J, 29, 270, 10.1093/eurheartj/ehm342 Gami, 2007, Obstructive sleep apnea, obesity, and the risk of incident atrial fibrillation, J Am Coll Cardiol, 49, 565, 10.1016/j.jacc.2006.08.060 Kannel, 1974, Role of diabetes in congestive heart failure: the Framingham study, Am J Cardiol, 34, 29, 10.1016/0002-9149(74)90089-7 Kenchaiah, 2002, Obesity and the risk of heart failure, N Engl J Med, 347, 305, 10.1056/NEJMoa020245 Kuller, 1995, Subclinical disease as an independent risk factor for cardiovascular disease, Circulation, 92, 720, 10.1161/01.CIR.92.4.720 Wong CX ST, 2015, Obesity and the risk of incident, post-operative, and post-ablation atrial fibrillation: a meta-analysis of 626,603 individuals in 51 studies, J Am Coll Cardiol EP, 1, 139 Fang, 2004, Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications, Endocr Rev, 25, 543, 10.1210/er.2003-0012 Seferović, 2015, Clinical diabetic cardiomyopathy: a two-faced disease with restrictive and dilated phenotypes, Eur Heart J, 36, 1718, 10.1093/eurheartj/ehv134 Kosmala, 2012, Left ventricular function impairment in patients with normal-weight obesity: contribution of abdominal fat deposition, profibrotic state, reduced insulin sensitivity, and proinflammatory activation, Circ Cardiovasc Imaging, 5, 349, 10.1161/CIRCIMAGING.111.969956 Venteclef, 2015, Human epicardial adipose tissue induces fibrosis of the atrial myocardium through the secretion of adipo-fibrokines, Eur Heart J, 36, 795, 10.1093/eurheartj/eht099 Alpert, 2014, Heart failure and obesity in adults: pathophysiology, clinical manifestations and management, Curr Heart Fail Rep, 11, 156, 10.1007/s11897-014-0197-5 Eguchi, 2008, Association between diabetes mellitus and left ventricular hypertrophy in a multiethnic population, Am J Cardiol, 101, 1787, 10.1016/j.amjcard.2008.02.082 Di Bello, 2013, New echocardiographic techniques in the evaluation of left ventricular function in obesity, Obesity (Silver Spring), 21, 881, 10.1002/oby.20071 Fang, 2005, Determinants of subclinical diabetic heart disease, Diabetologia, 48, 394, 10.1007/s00125-004-1632-z Fang, 2003, Echocardiographic detection of early diabetic myocardial disease, J Am Coll Cardiol, 41, 611, 10.1016/S0735-1097(02)02869-3 Wong, 2004, Alterations of left ventricular myocardial characteristics associated with obesity, Circulation, 110, 3081, 10.1161/01.CIR.0000147184.13872.0F Kosmala, 2004, Comparison of left ventricular function by tissue Doppler imaging in patients with diabetes mellitus without systemic hypertension versus diabetes mellitus with systemic hypertension, Am J Cardiol, 94, 395, 10.1016/j.amjcard.2004.04.048 Ernande, 2011, Diastolic dysfunction in patients with type 2 diabetes mellitus: is it really the first marker of diabetic cardiomyopathy?, J Am Soc Echocardiogr, 24, 1268, 10.1016/j.echo.2011.07.017 From, 2010, The development of heart failure in patients with diabetes mellitus and pre-clinical diastolic dysfunction a population-based study, J Am Coll Cardiol, 55, 300, 10.1016/j.jacc.2009.12.003 Boyer, 2004, Prevalence of ventricular diastolic dysfunction in asymptomatic, normotensive patients with diabetes mellitus, Am J Cardiol, 93, 870, 10.1016/j.amjcard.2003.12.026 Turkbey, 2010, The impact of obesity on the left ventricle: the Multi-Ethnic Study of Atherosclerosis (MESA), J Am Coll Cardiol Img, 3, 266, 10.1016/j.jcmg.2009.10.012 Fang, 2004, Relationship between longitudinal and radial contractility in subclinical diabetic heart disease, Clin Sci (Lond), 106, 53, 10.1042/CS20030153 Wang, 2016, Update on echocardiographic assessment in diabetes mellitus, Curr Cardiol Rep, 18, 85, 10.1007/s11886-016-0759-0 Piya, 2011, Abnormal left ventricular torsion and cardiac autonomic dysfunction in subjects with type 1 diabetes mellitus, Metabolism, 60, 1115, 10.1016/j.metabol.2010.12.004 Crendal, 2013, Myocardial deformation and twist mechanics in adults with metabolic syndrome: impact of cumulative metabolic burden, Obesity (Silver Spring), 21, E679, 10.1002/oby.20537 Ernande, 2014, Longitudinal myocardial strain alteration is associated with left ventricular remodeling in asymptomatic patients with type 2 diabetes mellitus, J Am Soc Echocardiogr, 27, 479, 10.1016/j.echo.2014.01.001 Jellis, 2011, Usefulness of at rest and exercise hemodynamics to detect subclinical myocardial disease in type 2 diabetes mellitus, Am J Cardiol, 107, 615, 10.1016/j.amjcard.2010.10.024 Fang, 2003, Patients with early diabetic heart disease demonstrate a normal myocardial response to dobutamine, J Am Coll Cardiol, 42, 446, 10.1016/S0735-1097(03)00654-5 Kim, 2011, Impact of left ventricular longitudinal diastolic functional reserve on clinical outcome in patients with type 2 diabetes mellitus, Heart, 97, 1233, 10.1136/hrt.2010.219220 Kosmala, 2007, Subclinical right ventricular dysfunction in diabetes mellitus–an ultrasonic strain/strain rate study, Diabet Med, 24, 656, 10.1111/j.1464-5491.2007.02101.x Wong, 2006, Association of subclinical right ventricular dysfunction with obesity, J Am Coll Cardiol, 47, 611, 10.1016/j.jacc.2005.11.015 Muranaka, 2009, Quantitative assessment of left ventricular and left atrial functions by strain rate imaging in diabetic patients with and without hypertension, Echocardiography, 26, 262, 10.1111/j.1540-8175.2008.00805.x Murthy, 2012, Association between coronary vascular dysfunction and cardiac mortality in patients with and without diabetes mellitus, Circulation, 126, 1858, 10.1161/CIRCULATIONAHA.112.120402 Moir, 2006, Relationship between myocardial perfusion and dysfunction in diabetic cardiomyopathy: a study of quantitative contrast echocardiography and strain rate imaging, Heart, 92, 1414, 10.1136/hrt.2005.079350 Ahmari, 2008, Impact of individual and cumulative coronary risk factors on coronary flow reserve assessed by dobutamine stress echocardiography, Am J Cardiol, 101, 1694, 10.1016/j.amjcard.2008.02.055 Atar, 2012, Coronary flow reserve in patients with diabetes mellitus and prediabetes, Echocardiography, 29, 634, 10.1111/j.1540-8175.2012.01668.x Erdogan, 2013, Effects of prediabetes and diabetes on left ventricular and coronary microvascular functions, Metabolism, 62, 1123, 10.1016/j.metabol.2013.02.011 von Bibra, 2004, Augmented metabolic control improves myocardial diastolic function and perfusion in patients with non-insulin dependent diabetes, Heart, 90, 1483, 10.1136/hrt.2003.020842 Topcu, 2006, Metformin therapy improves coronary microvascular function in patients with polycystic ovary syndrome and insulin resistance, Clin Endocrinol (Oxf), 65, 75, 10.1111/j.1365-2265.2006.02551.x Quiñones, 2004, Coronary vasomotor abnormalities in insulin-resistant individuals, Ann Intern Med, 140, 700, 10.7326/0003-4819-140-9-200405040-00009 Garg, 2015, Mineralocorticoid receptor blockade improves coronary microvascular function in individuals with type 2 diabetes, Diabetes, 64, 236, 10.2337/db14-0670 Hansen, 2002, C-peptide exerts beneficial effects on myocardial blood flow and function in patients with type 1 diabetes, Diabetes, 51, 3077, 10.2337/diabetes.51.10.3077 Jellis, 2011, Association of imaging markers of myocardial fibrosis with metabolic and functional disturbances in early diabetic cardiomyopathy, Circ Cardiovasc Imaging, 4, 693, 10.1161/CIRCIMAGING.111.963587 Di Bello, 2006, Obesity cardiomyopathy: is it a reality? An ultrasonic tissue characterization study, J Am Soc Echocardiogr, 19, 1063, 10.1016/j.echo.2006.03.033 Kosmala, 2012, Integrated backscatter as a fibrosis marker in the metabolic syndrome: association with biochemical evidence of fibrosis and left ventricular dysfunction, Eur Heart J Cardiovasc Imaging, 13, 459, 10.1093/ejechocard/jer291 Iacobellis, 2009, Echocardiographic epicardial fat: a review of research and clinical applications, J Am Soc Echocardiogr, 22, 1311, 10.1016/j.echo.2009.10.013 Serrano-Ferrer, 2016, Effects of lifestyle intervention on left ventricular regional myocardial function in metabolic syndrome patients from the RESOLVE randomized trial, Metabolism, 65, 1350, 10.1016/j.metabol.2016.05.006 Rabkin, 2015, Comparison of reducing epicardial fat by exercise, diet or bariatric surgery weight loss strategies: a systematic review and meta-analysis, Obes Rev, 16, 406, 10.1111/obr.12270 Wong, 2011, Pericardial fat is associated with atrial fibrillation severity and ablation outcome, J Am Coll Cardiol, 57, 1745, 10.1016/j.jacc.2010.11.045 Mahajan, 2015, Electrophysiological, electroanatomical, and structural remodeling of the atria as consequences of sustained obesity, J Am Coll Cardiol, 66, 1, 10.1016/j.jacc.2015.04.058 Mehra, 2004, Obesity and suppressed B-type natriuretic peptide levels in heart failure, J Am Coll Cardiol, 43, 1590, 10.1016/j.jacc.2003.10.066 2015, (8) Cardiovascular disease and risk management, Diabetes Care, 38, S49 Holland, 2015, Subclinical LV dysfunction and 10-year outcomes in type 2 diabetes mellitus, Heart, 101, 1061, 10.1136/heartjnl-2014-307391 Ikonomidis, 2007, Weight loss after bariatric surgery improves aortic elastic properties and left ventricular function in individuals with morbid obesity: a 3-year follow-up study, J Hypertens, 25, 439, 10.1097/HJH.0b013e3280115bfb Pi-Sunyer, 2007, Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the look AHEAD trial, Diabetes Care, 30, 1374, 10.2337/dc07-0048 Leung, 2016, Weight loss with sleeve gastrectomy in obese type 2 diabetes mellitus: impact on cardiac function, Obes Surg, 26, 321, 10.1007/s11695-015-1748-x Kosmala, 2009, Improvement of left ventricular function by lifestyle intervention in obesity: contributions of weight loss and reduced insulin resistance, Diabetologia, 52, 2306, 10.1007/s00125-009-1507-4 Abed, 2013, Effect of weight reduction and cardiometabolic risk factor management on symptom burden and severity in patients with atrial fibrillation: a randomized clinical trial, JAMA, 310, 2050, 10.1001/jama.2013.280521 Pathak, 2015, Long-Term Effect of Goal-Directed Weight Management in an Atrial Fibrillation Cohort: A Long-Term Follow-Up Study (LEGACY), J Am Coll Cardiol, 65, 2159, 10.1016/j.jacc.2015.03.002 Marwick, 2009, Exercise training for type 2 diabetes mellitus: impact on cardiovascular risk: a scientific statement from the American Heart Association, Circulation, 119, 3244, 10.1161/CIRCULATIONAHA.109.192521 Hare, 2011, Application of an exercise intervention on the evolution of diastolic dysfunction in patients with diabetes mellitus: efficacy and effectiveness, Circ Heart Fail, 4, 441, 10.1161/CIRCHEARTFAILURE.110.959312 Cassidy, 2017, High-intensity interval training: a review of its impact on glucose control and cardiometabolic health, Diabetologia, 60, 7, 10.1007/s00125-016-4106-1 Schuster, 2012, Diastolic dysfunction and intraventricular dyssynchrony are restored by low intensity exercise training in obese men, Obesity (Silver Spring), 20, 134, 10.1038/oby.2011.270 Pathak, 2015, Impact of CARDIOrespiratory FITness on Arrhythmia Recurrence in Obese Individuals With Atrial Fibrillation: The CARDIO-FIT Study, J Am Coll Cardiol, 66, 985, 10.1016/j.jacc.2015.06.488 Leung, 2016, Impact of improved glycemic control on cardiac function in type 2 diabetes mellitus, Circ Cardiovasc Imaging, 9, e003643, 10.1161/CIRCIMAGING.115.003643 Jarnert, 2009, A randomized trial of the impact of strict glycaemic control on myocardial diastolic function and perfusion reserve: a report from the DADD (Diabetes mellitus And Diastolic Dysfunction) study, Eur J Heart Fail, 11, 39, 10.1093/eurjhf/hfn018 Kosmala, 2011, A randomized study of the beneficial effects of aldosterone antagonism on LV function, structure, and fibrosis markers in metabolic syndrome, J Am Coll Cardiol Img, 4, 1239, 10.1016/j.jcmg.2011.08.014 Kosmala, 2013, Fibrosis and cardiac function in obesity: a randomised controlled trial of aldosterone blockade, Heart, 99, 320, 10.1136/heartjnl-2012-303329 Jellis, 2014, Biomarker and imaging responses to spironolactone in subclinical diabetic cardiomyopathy, Eur Heart J Cardiovasc Imaging, 15, 776, 10.1093/ehjci/jeu013